More articles from Review

Open Access
Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides BRCA1 and BRCA2 as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies
IOANNIS A. VOUTSADAKIS and ATHINA STRAVODIMOU

Anticancer Research March 2023, 43 (3) 967-981; DOI: https://doi.org/10.21873/anticanres.16241
Open Access
Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA

Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
Open Access
The Potential Impact of New Drug and Therapeutic Modalities on Drug Resistance to Renal Cell Carcinoma
PEDRO CAETANO PINTO

Anticancer Research March 2023, 43 (3) 983-991; DOI: https://doi.org/10.21873/anticanres.16242
Open Access
Intramedullary Spinal Cord Metastases from Breast Cancer: A Systematic Review
GIANLUCA SCALIA, ROBERTA COSTANZO, ANNA VIOLA, LAPO BONOSI, MASSIMILIANO PORZIO, ANDREA GIOVANNINI, FRANCESCA GRAZIANO, DOMENICO GERARDO IACOPINO, ROSARIO MAUGERI, GIOVANNI FEDERICO NICOLETTI and GIUSEPPE EMMANUELE UMANA

Anticancer Research February 2023, 43 (2) 523-535; DOI: https://doi.org/10.21873/anticanres.16189
Open Access
The Latest Treatments for Cancer Cachexia: An Overview
HAYATO WATANABE and TAKASHI OSHIMA

Anticancer Research February 2023, 43 (2) 511-521; DOI: https://doi.org/10.21873/anticanres.16188
Open Access
Transglutaminase-4 (Prostate Transglutaminase), a Potential Biological Factor and Clinical Indicator for the Diagnosis and Prognosis of Prostate Cancer
LIN YE, ANDREW J. SANDERS and WEN G. JIANG

Anticancer Research January 2023, 43 (1) 291-296; DOI: https://doi.org/10.21873/anticanres.16162
Open Access
The Role of Genetic Polymorphisms in the Diagnosis and Management of Prostate Cancer: An Update
LUCIO DELL’ATTI and GIANLUCA AGUIARI

Anticancer Research January 2023, 43 (1) 317-322; DOI: https://doi.org/10.21873/anticanres.16166
Open Access
Evolution of Models of Prostate Cancer: Their Contribution to Current Therapies
ANA I. FAUSTINO-ROCHA, CATARINA JOTA-BAPTISTA, ELISABETE NASCIMENTO-GONÇALVES and PAULA A. OLIVEIRA

Anticancer Research January 2023, 43 (1) 323-333; DOI: https://doi.org/10.21873/anticanres.16167
Open Access
Renal Impairment: A Major Adverse Event in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
HIROSHI MASUDA

Anticancer Research January 2023, 43 (1) 305-309; DOI: https://doi.org/10.21873/anticanres.16164
Open Access
Radiotherapy in Prostate Brain Metastases: A Review of the Literature
CAROLINA DE LA PINTA

Anticancer Research January 2023, 43 (1) 311-315; DOI: https://doi.org/10.21873/anticanres.16165

Main menu

User menu

Search

More articles from Review

Pages